Impact of the Avastin Case on Prescribing Medicines Off‐label

Prescriber - United Kingdom
doi 10.1002/psb.1788
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

The Influence of the Pharmaceutical Industry on the Off-Label Use of Its Medicines

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2002English

Off-Label Prescribing in Pregnancy—a Case of Risky Business or Business as Usual?

European Journal of Obstetrics, Gynecology and Reproductive Biology
GynecologyReproductive MedicineObstetrics
2015English

Comment On: The Influence of the Pharmaceutical Industry on the Off-Label Use of Its Medicines

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2002English

Off-Label Medication Prescribing Patterns in Pediatrics: An Update

Hospital pediatrics
MedicineChild HealthPediatricsPerinatology
2019English

Prescribing Gabapentin Off Label: Perspectives From Psychiatry, Pain and Neurology Specialists

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Off-Label Prescribing: A Call for Heightened Professional and Government Oversight

Journal of Law, Medicine and Ethics
MedicineLegal AspectsEthicsIssuesHealth Policy
2009English

Off-Label Prescribing in Pediatric Inpatients With Pneumonia in a Children's Hospitaal

JURNAL ILMU KEFARMASIAN INDONESIA
2018English

Off-Label Prescribing for Children With Chronic Diseases in Nigeria; Findings and Implications

Expert Opinion on Drug Safety
MedicinePharmacology
2017English

Off Label Prescribing to Children in Primary Care in Germany: Retrospective Cohort Study

BMJ
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy